The effect of moderate to severe endometriosis on expression of growth differentiation factor-9 mRNA in human granulosa cells under controlled ovarian hyperstimulation
Observational
OA: gold
CC0
⤵ 5 in-corpus citations
AI-generated summary
Moderate to severe endometriosis significantly reduced GDF-9 mRNA expression in human granulosa cells, correlating with poorer oocyte maturation and embryo quality compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PURPOSE: To investigate the effect of moderate to severe endometriosis on mRNA expression of growth differentiation factor-9 (GDF-9) in the granulosa cells of mature follicles.
METHODS: Follicular fluid (FF) was obtained from 13 patients with moderate to severe endometriosis and 11 without endometriosis, as a control group, and GDF-9 protein levels in both were assayed by western blotting. mRNA expression by GDF-9 and LH receptor (LHR) in granulosa cells obtained from all patients in the study were investigated by StepOne Real-Time PCR.
RESULTS: Although GDF-9 in FF from patients with endometriosis was no different from that of controls, GDF-9 mRNA expression in granulosa cells of patients with endometriosis was statistically significantly lower than for the control group. The number of oocytes and high-quality embryos was positively correlated with GDF-9 mRNA expression in controls but not in patients with endometriosis Moreover, a negative correlation was identified between GDF-9 mRNA expression and serum estrogen and progesterone levels in the control group, whereas no correlation was observed for the endometriosis group.
CONCLUSIONS: Moderate to severe endometriosis can significantly reduce GDF-9 mRNA expression in the granulosa cells of patients with the disease compared with those without, thus causing poor oocyte maturation and lower embryo quality.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (27)
- Clinical practice. Endometriosis via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Endometriosis and IVF: effect of prior therapy via openalex
- Endometriosis and luteal phase defect via openalex
- Growth differentiation factor 9 concentration in the follicular fluid of infertile women with endometriosis via openalex
- Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer via openalex
- Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation via openalex
- W1996938657 via openalex
- W2011377754 via openalex
- W2016019447 via openalex
- W2033418521 via openalex
- W2048546103 via openalex
- W2106487699 via openalex
- W2107096204 via openalex
- W2107277218 via openalex
- W2127151362 via openalex
- W2153922745 via openalex
- W2405709589 via openalex
- W4232697992 via openalex
- W4245765194 via openalex
- W4285719527 via openalex
- W1842467898 via openalex
- W1964184380 via openalex
- W1967090815 via openalex
- W1972428774 via openalex
- W1975833969 via openalex
- W1993178429 via openalex
Cited by (4)
- The Effect of Endometriosis on the Quality of Oocytes and Embryos Obtained by IVF 2024
- Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis 2022
- The impact of phthalate on reproductive function in women with endometriosis 2021
- Expressions of growth differentiation factor-9 on granulosa cells of infertile women with endometriosis undergoing <i>in vitro</i> fertilization 2018
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:21:08.819620+00:00
License: CC0
· commercial use OK